Summary sheet on Commission
Review (ref. XXIV/1991/97)
Ingredient : Acetyl
ethyl tetramethyl tetralin.
CAS n° : 88-29-9
Function and max in use
concentration : fragrance
ingredient, 1,2 % in perfumes.
Relevant toxicity data :
Assessment of
chronic/sub-chronic toxicity :
Very toxic for the CNS in
repeated dose toxicity studies
by dermal application (13 &
26 w.) Ý very low NOAEL.
Toxicokinetics:
- Wide distribution in
lipid rich organs after i.p. or
i.v. inj.
Classification: 2a (See
Classification of Substances)
SCCNFP Opinion
After i.p. or i.v.
injection, Acetyl ethyl
tetramethyl tetralin (AETT) is
widely distributed in lipid
rich organs, mainly brain,
spinal cord and nerve tracts
and is extensively reabsorbed
after redistribution via the
liver.
In sub-chronic dermal
studies, AETT treated animals
exhibited clinical signs of
neuro-toxicity confirmed by
histological examination.
Neuropathological changes
occurred at very low doses and
were dose and time dependant.
NOAEL (rat skin application) =
3 mg/Kg/d.
The available data
support the conclusion that
AETT constitutes a hazard for
the CNS after dermal exposure.
The SCCNFP is of the opinion
that AETT must not be used in
cosmetic products.
Statement on the
toxicological evaluation
The SCCNFP is the
scientific advisory body to the
European Commission in matters
of consumer protection with
respect to cosmetics and
non-food products intended for
consumers.
The Commission's general
policy regarding research on
animals supports the
development of alternative
methods to replace or to reduce
animal testing when possible.
In this context, the SCCNFP has
a specific working group on
alternatives to animal testing
which, in co-operation with
other Commission services such
as ECVAM (European Centre for
Validation of Alternative
Methods), evaluates these
methods.
SCCNFP opinions include
evaluations of experiments
using laboratory animals; such
tests are conducted in
accordance with all legal
provisions and preferably under
chemical law regulations. Only
in cases where no alternative
method is available will such
tests be evaluated and the
resulting data accepted, in
order to meet the fundamental
requirements of the protection
of consumer health.